Certified by Founder
Lodge
AAVantgarde Bio
start up
Italy
- Milan, Lombardy
- 07/06/2023
- Series A
- $65,333,745
Delivering the next generation gene therapies
- Industry Biotechnology Research
- Website https://www.aavantgardebio.com/
- LinkedIn https://www.linkedin.com/company/aavantgarde-bio/
Related People
Natalia Misciattelli Mocenigo SoranzoFounder
United Kingdom -
Victoria, England
A well-rounded Biotech business executive with a proven track record of delivering shareholder value internationally.
Science and finance background combined with a passion for working in cutting edge technology. Creative thinker with expertise in generating and executing strategies to deliver company growth.
Experienced in building and leading teams through complex growth and transformation whilst managing multiple stakeholder groups in a fast pace evolving landscape. Strong leader skilled at building strategic relationships to drive opportunities and change in organizations.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)